Zvavahera Chirenje, MD

Title(s)Academic Coordinator III, Ob/Gyn, Reproductive Sciences
SchoolSchool of Medicine
Address550 16th Street
San Francisco CA 94158
Phone263-470-4890
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    The Bixby Center for Global Reproductive Health - Annual Research Day Conference
    NIH R13AI132016Aug 1, 2017 - Jul 31, 2018
    Role: Principal Investigator
    UZ-UCSF CTU
    NIH UM1AI069436Mar 1, 2007 - Nov 30, 2027
    Role: Principal Investigator
    UZ-UCSF Clinical Trials Unit
    NIH U01AI069436Mar 1, 2007 - Nov 30, 2013
    Role: Principal Investigator

    Collapse Featured Content 
    Collapse Global Health Equity

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prevalent HPV infection increases the risk of HIV acquisition in African women: advancing the argument for HPV immunization. AIDS. 2021 Jun 24. Liu G, Mugo NR, Brown ER, Mgodi NM, Chirenje ZM, Marrazzo JM, Winer RL, Mansoor L, Palanee-Phillips T, Siva SS, Naidoo L, Jeenarain N, Gaffoor Z, Nair GL, Selepe P, Nakabiito C, Mkhize B, Mirembe BG, Taljaard M, Panchia R, Baeten JM, Balkus JE, Hladik F, Celum CL, Barnabas RV. PMID: 34172672.
      View in: PubMed   Mentions:    Fields:    
    2. Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping. PLoS One. 2021; 16(4):e0250426. Dube Mandishora RS, Rounge TB, Fitzpatrick M, Christiansen IK, Ambur OH, Lagström S, Stray-Pedersen B, Tommasino M, Palefsky J, Chirenje ZM. PMID: 33901223.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    3. Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation. Am J Reprod Immunol. 2021 07; 86(1):e13405. Matubu AT, Hillier SL, Meyn LA, Stoner KA, Mhlanga F, Mbizvo M, Maramba A, Chirenje ZM, Achilles SL. PMID: 33609312.
      View in: PubMed   Mentions:    Fields:    
    4. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. Lancet HIV. 2021 02; 8(2):e87-e95. Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G, Gati Mirembe B, Mhlanga F, Hunidzarira P, Mansoor LE, Siva S, Govender V, Makanani B, Naidoo L, Singh N, Nair G, Chinula L, Parikh UM, Mellors JW, Balán IC, Ngure K, van der Straten A, Scheckter R, Garcia M, Peda M, Patterson K, Livant E, Bunge K, Singh D, Jacobson C, Jiao Y, Hendrix CW, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Torjesen K, Nel A, Rosenberg Z, Soto-Torres LE, Hillier SL, Brown ER, MTN-025/HOPE Study Team . PMID: 33539762.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    5. Preferences and Acceptability of Vaginal Delivery Forms for HIV Prevention Among Women, Male Partners and Key Informants in South Africa and Zimbabwe: Qualitative Findings. AIDS Behav. 2021 Jan; 25(1):124-138. Musara P, Milford C, Shapley-Quinn MK, Weinrib R, Mutero P, Odoom E, Mgodi NM, Chirenje ZM, Hanif H, Clark MR, Smit J, van der Straten A, Montgomery ET, Quatro Study Team . PMID: 32588257.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Estimated costs for the delivery of safer conception strategies for HIV-discordant couples in Zimbabwe: a cost analysis. BMC Health Serv Res. 2020 Oct 12; 20(1):940. Hughes CS, Brown J, Murombedzi C, Chirenda T, Chareka G, Mhlanga F, Mateveke B, Gitome S, Makurumure T, Matubu A, Mgodi N, Chirenje Z, Kahn JG. PMID: 33046066.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    7. Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives. Am J Reprod Immunol. 2020 09; 84(3):e13287. Achilles SL, Meyn LA, Mhlanga FG, Matubu AT, Stoner KA, Beamer MA, Chirenje ZM, Hillier SL. PMID: 32533883.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    8. Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment. AIDS Behav. 2020 May; 24(5):1443-1451. Browne EN, Montgomery ET, Mansfield C, Boeri M, Mange B, Beksinska M, Schwartz JL, Clark MR, Doncel GF, Smit J, Chirenje ZM, van der Straten A. PMID: 31696371.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities. AIDS. 2020 03 15; 34(4):559-567. Reddy K, Kelly C, Brown ER, Jeenarain N, Naidoo L, Siva S, Bekker LG, Nair G, Makanani B, Chinula L, Mgodi N, Chirenje Z, Kiweewa FM, Marrazzo J, Bunge K, Soto-Torres L, Piper J, Baeten JM, Palanee-Phillips T, MTN-020/ASPIRE and MTN-003/VOICE Study Teams . PMID: 31764068.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    10. Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers. Am J Reprod Immunol. 2020 03; 83(3):e13210. Matubu A, Hillier SL, Meyn LA, Stoner KA, Mhlanga F, Mbizvo M, Maramba A, Chirenje ZM, Achilles SL. PMID: 31729087.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. Giant mucinous cystadenoma: a case report. J Med Case Rep. 2019 Jun 14; 13(1):181. Gwanzura C, Muyotcha AF, Magwali T, Chirenje ZM, Madziyire MG. PMID: 31196215.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    12. A case of twin reversed arterial perfusion (TRAP) sequence managed conservatively. Pan Afr Med J. 2019; 32:54. Ziki EM, Chirenje ZM, Madziyire MG. PMID: 31143359.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Validation of the GenoType® MTBDRplus Ver 2.0 assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates at UZCHS-CTRC TB research laboratory. Int J Mycobacteriol. 2019 Jan-Mar; 8(1):83-88. Stephen S, Muzhizhizhi D, Dhibi N, Chidemo T, Samaneka W, Matubu TA, Hakim JG, Chirenje ZM. PMID: 30860184.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    14. Anal human papillomavirus infection in HIV-positive men and women at two opportunistic infections clinics in Harare, Zimbabwe. BMC Public Health. 2018 Nov 14; 18(1):1260. Chinyowa S, Palefsky JM, Chirenje ZM, Makunike-Mutasa R, Munjoma M, Muguti GI. PMID: 30428859.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    15. The association of puerperal sepsis with HIV infection at two tertiary hospitals in Zimbabwe. Int J Gynaecol Obstet. 2019 Jan; 144(1):67-72. Majangara R, Chirenje ZM, Gidiri MF. PMID: 30343490.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol. 2018 06; 218(6):622.e1-622.e10. Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL. PMID: 29505773.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    17. Microbiology and clinical outcomes of puerperal sepsis: a prospective cohort study. J Obstet Gynaecol. 2018 Jul; 38(5):635-641. Majangara R, Gidiri MF, Chirenje ZM. PMID: 29447024.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    18. Misreporting of contraceptive hormone use in clinical research participants. Contraception. 2018 04; 97(4):346-353. Achilles SL, Mhlanga FG, Musara P, Poloyac SM, Chirenje ZM, Hillier SL. PMID: 28966052.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    19. The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples. J Clin Virol. 2017 09; 94:15-21. Livant E, Heaps A, Kelly C, Maharaj R, Samsunder N, Nhlangulela L, Karugaba P, Panchia R, Marrazzo J, Chirenje ZM, Parikh UM, VOICE Study Team . PMID: 28710996.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    20. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe. J Med Virol. 2017 09; 89(9):1671-1677. Dube Mandishora RS, Christiansen IK, Chin'ombe N, Duri K, Ngara B, Rounge TB, Meisal R, Ambur OH, Palefsky JM, Stray-Pedersen B, Chirenje ZM. PMID: 28390142.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    21. Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003). Sex Transm Dis. 2017 03; 44(3):135-140. Chirenje ZM, Gundacker HM, Richardson B, Rabe L, Gaffoor Z, Nair GL, Mirembe BG, Piper JM, Hillier S, Marrazzo J. PMID: 28178109.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    22. Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial. J Womens Health (Larchmt). 2017 06; 26(6):670-676. Akello CA, Bunge KE, Nakabiito C, Mirembe BG, Fowler MG, Mishra A, Marrazzo J, Chirenje ZM, Celum C, Balkus JE. PMID: 28437215.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population. PLoS One. 2016; 11(11):e0165821. Samaneka WP, Mandozana G, Tinago W, Nhando N, Mgodi NM, Bwakura-Dangarembizi MF, Munjoma MW, Gomo ZA, Chirenje ZM, Hakim JG. PMID: 27812172.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    24. Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit? AIDS Behav. 2016 11; 20(11):2654-2661. Mensch BS, Brown ER, Liu K, Marrazzo J, Chirenje ZM, Gomez K, Piper J, Patterson K, van der Straten A. PMID: 26906023.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    25. An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women. . 2016 07 01; 72(3):333-43. Balkus JE, Brown E, Palanee T, Nair G, Gafoor Z, Zhang J, Richardson BA, Chirenje ZM, Marrazzo JM, Baeten JM. PMID: 26918545.
      View in: PubMed   Mentions:
    26. Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [Contraception 2016; 93 (1): 25-31]. Contraception. 2016 Jul; 94(1):95. Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM. PMID: 27085419.
      View in: PubMed   Mentions: 1     Fields:    
    27. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med. 2016 12 01; 375(22):2121-2132. Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, Makanani B, Pather A, Naidoo L, Husnik M, Richardson BA, Parikh UM, Mellors JW, Marzinke MA, Hendrix CW, van der Straten A, Ramjee G, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Mayo A, Scheckter R, Berthiaume J, Livant E, Jacobson C, Ndase P, White R, Patterson K, Germuga D, Galaska B, Bunge K, Singh D, Szydlo DW, Montgomery ET, Mensch BS, Torjesen K, Grossman CI, Chakhtoura N, Nel A, Rosenberg Z, McGowan I, Hillier S, MTN-020–ASPIRE Study Team . PMID: 26900902.
      View in: PubMed   Mentions: 260     Fields:    Translation:HumansCellsCTClinical Trials
    28. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial. Contraception. 2016 Jan; 93(1):25-31. Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM. PMID: 26519646.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    29. Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial. . 2015 Oct 01; 70(2):212-7. Balkus JE, Nair G, Montgomery ET, Mishra A, Palanee-Phillips T, Ramjee G, Panchia R, Selepe P, Richardson BA, Chirenje ZM, Marrazzo JM. PMID: 26049280.
      View in: PubMed   Mentions:
    30. Hematological and biochemical laboratory reference intervals for Zimbabwean adolescents. Clin Lab. 2015; 61(1-2):101-11. Gomani P, Matubu AT, Mujuru HA, Munjoma MW, Tinago W, Mandozana G, Hakim JG, Gomo ZA, Chirenje ZM. PMID: 25807644.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. J Infect Dis. 2012 Dec 15; 206(12):1931-5. Dezzutti CS, Richardson BA, Marrazzo JM, Tugetman J, Ramjee G, Taha T, Chirenje ZM, Abdool Karim SS, Hillier SL, Herold BC, MTN Biomedical Sciences Working Group , HPTN 035 Protocol Team . PMID: 22966121.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    32. Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel. J Int AIDS Soc. 2012 Aug 27; 15(2):17376. Chirenje ZM, Mâsse BR, Maslankowski LA, Ramjee G, Coletti AS, Tembo TN, Magure TM, Soto-Torres L, Kelly C, Hillier S, Karim A. PMID: 22944480.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    33. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS. 2011 Apr 24; 25(7):957-66. Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, Moench TR, Piwowar-Manning E, Mâsse B, Hillier SL, Soto-Torres L, HIV Prevention Trials Network (HPTN) 035 Study Team . PMID: 21330907.
      View in: PubMed   Mentions: 116     Fields:    Translation:HumansCellsCTClinical Trials
    34. Acceptability of heat treating breast milk to prevent mother-to-child transmission of human immunodeficiency virus in Zimbabwe: a qualitative study. J Hum Lact. 2006 Feb; 22(1):48-60. Israel-Ballard KA, Maternowska MC, Abrams BF, Morrison P, Chitibura L, Chipato T, Chirenje ZM, Padian NS, Chantry CJ. PMID: 16467287.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsPHPublic Health
    35. The CONRAD/WHO Update 2000 colposcopy manual: how well is it working? . 2004 Oct; 37 Suppl 3:S150-1. Njoroge B, Chirenje ZM, Pandey B, Mirembe F, Joshi S, Low-Beer N, Maslankowski LA. PMID: 16419263.
      View in: PubMed   Mentions:
    Zvavahera's Networks
    Concepts (199)
    Derived automatically from this person's publications.
    _
    Co-Authors (4)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _